<DOC>
	<DOCNO>NCT03083431</DOCNO>
	<brief_summary>Extremely premature infant risk develop potentially blind eye disease , call retinopathy prematurity ( ROP ) . Currently available treatment , consist laser surgery injection drug eye ball , may prevent case permanent ROP-mediated blindness . Both type treatment associate significant cost side effect . An orally administer drug commonly use treat hypertension , propranolol , may effective halt progression ROP severe stage , suggest preliminary data two small study . Propranolol use decade adult patient also newborn infant heart diseases . Moreover , license 2014 use newborn infant hemangiomas European Union , Switzerland United States . As severe ( threshold ) ROP overall rare disease , effectiveness propranolol combat ROP assess large , multicenter randomize control trial involve hospital care extremely preterm infant diverse origin .</brief_summary>
	<brief_title>Propranolol Prevention Threshold Retinopathy Prematurity</brief_title>
	<detailed_description>Threshold Retinopathy Prematurity ( ROP ) , observed fraction extremely premature infant , characterize retinal vessel proliferation threaten vision secondary retinal detachment . Currently available treatment ( ablative laser surgery intravitreal anti-VEGF injection ) may prevent case permanent ROP-mediated blindness associate significant cost side effect . Orally administer propranolol , commonly use drug treat hypertension , may effective halt progression ROP severe stage , suggest preliminary data two small study . Propranolol use decade adult patient also newborn infant heart diseases . Moreover , license 2014 use newborn infant hemangiomas European Union , Switzerland United States . This multicenter randomize placebo-controlled trial aim ass whether oral propranolol give extremely premature infant 28 week gestational age reduce rate threshold ROP .</detailed_description>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Retinopathy Prematurity</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>Preterm infant bear 28 week gestation Birth weight 1250 g Alive 5 week age Corrected gestational age 31*0/7 36*6/7 week Ophthalmoscopic evidence incipient ROP ( stage 1 2 , without plus disease ) Informed parental consent ROP stage 3 time inclusion ( endpoint already reach ) Thyrotoxicosis congenital heart diseases require openlabel propranolol treatment ( tetralogy Fallot , paroxysmal supraventricular tachycardia , long QT syndrome ) Atrioventricular block grade 2 3 ( contraindication propranolol ) Sinuatrial block ( contraindication propranolol ) PHACE syndrome ( posterior fossa anomaly , large infantile hemangioma face , neck , and/or scalp , arterial lesion , cardiac abnormalities/coarctation aorta , eye anomaly ) ( risk cerebrovascular complication ) Very large hemangioma ( risk hyperkalemia ) Major congenital malformation know chromosomal anomaly Colobomas eye malformation Heart rate consistently &lt; 100/min Noninvasive mean arterial pressure consistently &lt; 40 mmHg Medication clonidine antiarrhythmic drug include amiodarone , propafenone , lidocaine , digoxin/digitoxin , quinidine ( pharmacodynamic interaction ) Medication rifampicin phenobarbitone ( enhance metabolic clearance ) Persistent hyperkalemia ( serum potassium &gt; 5.9 mM ) Severe liver dysfunction ( GPT &gt; 900 U/l ) Chronic kidney impairment ( creatinine &gt; 1.3 mg/dl [ 100 µM ] ) Persistent hypoglycemia ( blood glucose &lt; 36 mg/dl [ 2.0 mM ] ) Persistent neutropenia ( absolute neutrophil count &lt; 1,000/µL )</criteria>
	<gender>All</gender>
	<minimum_age>5 Weeks</minimum_age>
	<maximum_age>15 Weeks</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>